Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Winston

Showing results (51-60 of 241) with videos related to

Pageof 25
Sort By:
AIDS (London, England)|April 3, 2004
Which nucleoside and nucleotide backbone combinations select for the K65R mutation in HIV-1 reverse transcriptaseAlan Winston, Anton Pozniak, Sundhiya Mandalia, et al.
The British Journal of Radiology|March 9, 2016
A comparison of two post-processing analysis methods to quantify cerebral metabolites measured via proton magnetic resonance spectroscopy in HIV diseaseJoseph Scott, Jonathan Underwood, Lucy J Garvey, et al.
The Journal of Antimicrobial Chemotherapy|December 30, 2015
Simulation of the impact of rifampicin on once-daily darunavir/ritonavir pharmacokinetics and dose adjustment strategies: a population pharmacokinetic approachLaura Dickinson, Alan Winston, Marta Boffito, et al.
Plos One|April 12, 2018
Medicalising normality? Using a simulated dataset to assess the performance of different diagnostic criteria of HIV-associated cognitive impairmentJonathan Underwood, Davide De Francesco, Robert Leech, et al.
Public Health Nutrition|October 25, 2007
Validity of carbohydrate, glycaemic index and glycaemic load data obtained using a semi-quantitative food-frequency questionnaireAlan Winston Barclay, Victoria Mary Flood, Jennie Cecile Brand-Miller, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 3, 2018
Multivariate Pattern Analysis of Volumetric Neuroimaging Data and Its Relationship With Cognitive Function in Treated HIV DiseaseJonathan Underwood, James H Cole, Robert Leech, et al.
AIDS (London, England)|July 1, 2009
Detectable cerebrospinal fluid HIV RNA with associated neurological deficits, despite suppression of HIV replication in the plasma compartmentLucy J Garvey, Alex Everitt, Alan Winston, et al.
Journal of the International AIDS Society|November 14, 2014
Simulation of the impact of rifampicin on darunavir/ritonavir PK and dose adjustment strategies in HIV-infected patients: a population PK approachLaura Dickinson, Alan Winston, Marta Boffito, et al.
AIDS (London, England)|May 4, 2021
Response to: Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study periodSam Nightingale, Anna J Dreyer, Magnus Gisslén, et al.
HIV Clinical Trials|August 26, 2010
Neuropsychiatric adverse events with ritonavir-boosted darunavir monotherapy in HIV-infected individuals: a randomised prospective studyAlan Winston, Gerd Fätkenheuer, Jose Arribas, et al.
Pageof 25

Showing results (51-60 of 241) with videos related to

Sort By:
Pageof 25
AIDS (London, England)|April 3, 2004
Which nucleoside and nucleotide backbone combinations select for the K65R mutation in HIV-1 reverse transcriptaseAlan Winston, Anton Pozniak, Sundhiya Mandalia, et al.
The British Journal of Radiology|March 9, 2016
A comparison of two post-processing analysis methods to quantify cerebral metabolites measured via proton magnetic resonance spectroscopy in HIV diseaseJoseph Scott, Jonathan Underwood, Lucy J Garvey, et al.
The Journal of Antimicrobial Chemotherapy|December 30, 2015
Simulation of the impact of rifampicin on once-daily darunavir/ritonavir pharmacokinetics and dose adjustment strategies: a population pharmacokinetic approachLaura Dickinson, Alan Winston, Marta Boffito, et al.
Plos One|April 12, 2018
Medicalising normality? Using a simulated dataset to assess the performance of different diagnostic criteria of HIV-associated cognitive impairmentJonathan Underwood, Davide De Francesco, Robert Leech, et al.
Public Health Nutrition|October 25, 2007
Validity of carbohydrate, glycaemic index and glycaemic load data obtained using a semi-quantitative food-frequency questionnaireAlan Winston Barclay, Victoria Mary Flood, Jennie Cecile Brand-Miller, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 3, 2018
Multivariate Pattern Analysis of Volumetric Neuroimaging Data and Its Relationship With Cognitive Function in Treated HIV DiseaseJonathan Underwood, James H Cole, Robert Leech, et al.
AIDS (London, England)|July 1, 2009
Detectable cerebrospinal fluid HIV RNA with associated neurological deficits, despite suppression of HIV replication in the plasma compartmentLucy J Garvey, Alex Everitt, Alan Winston, et al.
Journal of the International AIDS Society|November 14, 2014
Simulation of the impact of rifampicin on darunavir/ritonavir PK and dose adjustment strategies in HIV-infected patients: a population PK approachLaura Dickinson, Alan Winston, Marta Boffito, et al.
AIDS (London, England)|May 4, 2021
Response to: Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study periodSam Nightingale, Anna J Dreyer, Magnus Gisslén, et al.
HIV Clinical Trials|August 26, 2010
Neuropsychiatric adverse events with ritonavir-boosted darunavir monotherapy in HIV-infected individuals: a randomised prospective studyAlan Winston, Gerd Fätkenheuer, Jose Arribas, et al.
Pageof 25